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ABSTRACT

This study explored treatment completion and self-efficacy of dual-diagnosis clients receiving cognitive
behavioral therapy (CBT) and a combination of CBT with motivational interviewing (MI) in an intensiveoutpatient setting. Results indicated that MI was associated with increased self-efficacy and treatment
completion.

Drug overdose is among the leading causes of death in the
United States (Winstanley et al., 2012). Between the years of
2010 and 2012, approximately 15.2 million females and 19.8
million males used illicit drugs in the United States (Diaz,
Horton, & Weiner, 2012). Researchers have reported that over
50% of individuals who abused drugs had a comorbid mental
health disorder (Diaz et al., 2012), and approximately 75% of
individuals who were diagnosed with a substance use disorder
(SUD) had a concomitant, treatable mental health diagnosis
in their lifetime (Cridland, Deane, Hsu, & Kelly, 2012). The
National Survey of Substance Abuse Treatment Services
(Substance
Abuse
and
Mental
Health
Services
Administration, Center for Behavioral Health Statistics and
Quality, 2014) reported that 43% of all clients treated for
substance abuse had a co-occurring mental health disorder.
The co-presentation of mental health disorders and SUDs,
hereafter referred to as dual diagnosis (DD), is prevalent in
the United States. The Substance Abuse and Mental Health
Administration (United States Department of Substance
Abuse and Mental Health Administration (SAMHSA), 2011)
reported that more than 6.8 million adults hold a DD.
The treatment of the DD population presents unique challenges to payers and clinicians. SAMHSA (United States
Department of Substance Abuse and Mental Health
Administration (SAMHSA), 2014) reported that the cost to
treat individuals with DD was over $100 billion annually.
Clinicians are faced with various obstacles in treating this population, including finding effective ways to engage and retain DD
clients in treatment. The presence of comorbid SUDs and mental
health disorders often exacerbates the effects of both diagnoses
(Westra, Aviram, & Doell, 2011) and has been historically linked
with poor treatment outcomes (Cridland et al., 2012).
While clients may present with a variety of combinations
of mental health disorders and SUDs, Cridland et al. (2012)
reported that the most prevalent DD combination included a
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mood disorder and alcohol use disorder. The co-presentation
of alcohol use and a mood disorder is significant, as an
interrelation between suicide attempts, depression, and alcohol addiction was reported (Lyne, O’Donoghue, Clancy, &
O’Gara, 2011). Researchers also found that the combination
of substance abuse and mood disorders significantly increased
the risk for completed suicide (Lyne et al., 2011). Clients with
DD reported higher frequencies of attempted suicide, resulting in recurring hospital stays (Błachut, Badura-Brzoza,
Jarzab, Gorczyca, & Hese, 2013).
Because of the risks and increased symptom severity associated with holding a DD, these clients have often required
extended inpatient treatment (Cridland et al., 2012). Those
with DD also experienced higher incidences of inpatient treatment with longer hospital stays for multiple treatments
(Benaiges, Prat, & Adan, 2012). When comparing DD clients
with those diagnosed with only a SUD, Cridland et al. (2012)
found that DD clients typically had higher relapse rates and
poorer treatment outcomes. These outcomes were cited as
being related to noncompliance with treatment recommendations. Additionally, poor treatment outcomes indicated that
those with DD experienced higher rates of relapse that were
associated with increased legal involvement and recidivism
when compared to those diagnosed with a standalone SUD.
Barriers to treatment completion
According to Tate et al. (2011), there was a significant treatment dropout rate among substance-abusing clients. Dropout
rates have been reported as high as 82% for intensive outpatient treatment. According to a systematic review by
Brorson, Arnevik, Rand-Hendriksen, and Duckert (2013), it
is more common for patients to drop out of treatment than to
complete. From their review, 21.5–43% of individuals in
detoxification drop out, 3–50% for outpatient treatment

20700 N Park Blvd, University Heights, OH 44118, USA.

2

leave, up to 57% in inpatient treatment terminate, and up to
67.7% fail to complete substitution treatment programs.
Because of complications when treating clients with co-occurring disorders in the United States, such as demographics,
social structure, and cognitive functioning, treatment outcomes remained poor (Sterling, Chi, & Hinman, 2011).
Treatment for the DD population is increasingly problematic
for practitioners, and challenges remain when assisting DD
clients in successfully completing treatment (Błachut et al.,
2013).
According to Patterson, Wolf, and Buckingham (2010), DD
clients experienced multiple barriers that affected treatment outcomes. The lack of an integrated treatment model for concurrent
treatment of both diagnoses has historically presented a barrier
for DD clients. For instance, when clients warranted dual treatment for DD, treatment facilities offered treatment for one
disorder, requiring clients to visit another facility for treatment
of the other diagnosis. Further, Patterson et al. (2010) found that
DD clients did not follow through with the treatment of a second
diagnoses, which remained untreated.
The DD population also has experienced barriers associated with having limited social support from family
(Horsfall, Cleary, Hunt, & Walter, 2009). Many DD clients
participate in maladaptive behaviors and engage in multiple
treatment episodes, causing family members to withdraw or
experience burnout (Horsfall et al., 2009). Clients with DD
also experienced lack of supportive sober housing and limited
employment options. In order to improve treatment rates for
this population, a combination of person-centered approaches
and cognitive therapy offered from a multi-disciplinary team
was suggested (Horsfall et al., 2009).
Self-efficacy and treatment completion
Self-efficacy encompasses a person’s belief about his or her
ability to make behavioral changes and is required for successful goal attainment (Greenfield, Venner, Kelly, Slaymaker,
& Bryan, 2012). Researchers found an association between
increasing self-efficacy and accomplishing goals, such as behavioral change treatment, for DD clients (Stein, Zane, & Grella,
2012). The results further showed that by increasing selfefficacy, clients were more likely to complete treatment.
Behavioral self-efficacy includes assessing the way people
think, behave, and feel about changing a behavior. For example, Greenfield et al. (2012) reported that a client with high
levels of behavioral self-efficacy also held a high level of
confidence in his or her ability to complete treatment goals
and objectives. These results also indicated that clients with
high levels of self-efficacy had high levels of belief in their
ability to stop the use of addictive substances. The effects of
self-efficacy on goal attainment were also demonstrated in a
study by Luszczynska, Benight, and Ciesak (2009) that found
that substance-abusing clients with high levels of behavioral
self-efficacy also held a stronger commitment to the plan of
change. Additionally, clients who reported high levels of
behavioral self-efficacy recovered from relapse quicker and
remained committed to the change process.
In contrast, Luszczynska et al. (2009) found that clients
with low levels of behavioral self-efficacy displayed low levels

of confidence in their abilities to achieve treatment goals (i.e.,
discontinue use) and objectives. These results further indicated that a client’s ability reduced when trying to make
necessary behavioral changes related to ending drug addictions (Luszczynska et al., 2009). Stein et al. (2012) further
demonstrated this finding, reporting that clients with low
levels of behavioral self-efficacy who used tobacco did not
attempt behavioral change strategies and often avoided
changes.
As the literature has reported, low levels of self-efficacy are
often associated with continued drug use behavior; however,
when exposed to self-efficacy enhancing programs, clients
appeared more likely to remain in drug cessation treatment
(Elfeddali, Bolman, Candel, Wiers, & De Vries, 2012). The
researchers further stated that exposing clients to psychological treatments such as motivational interviewing (MI;
Elfeddali et al., 2012) was beneficial for increasing clients’
confidence to remain in treatment. The study results also
revealed that clients who completely stopped using drugs
experienced high levels of self-efficacy to remain in treatment
during the research period, while those using drugs intermittently experienced significantly low levels of self-efficacy to
remain in treatment.
The study results indicated that self-efficacy significantly
increased through complete abstinence and not by gradual
cessation of drug use. In contrast, Mason, Deane, Kelly, and
Crowe (2009) found that clients with low levels of self-efficacy
during drug use treatment experienced increased depression
and stress. The results suggested that increasing self-efficacy
benefits increasing behavioral change. For instance, Mason
et al. (2009) found that introducing spirituality to drugaddicted clients as a coping strategy increased self-efficacy
and also reduced cravings and behavior relapse. The study
indicated that using interventions provided better control
over situational confidence for DD clients because of
increased self-efficacy.
Cognitive behavioral therapy and MI
Cognitive behavioral therapy (CBT) has been identified as a
leading treatment method used with the substance abusing
population (Aviram & Westra, 2011). High completion rates
of CBT treatment benefit positive social change by decreasing
DD clients’ relapse rates that, in turn, decrease early mortality.
Furthermore, abstaining from substance abuse is associated
with improved mental health and occupational functioning
for DD clients. These clients also experience less legal involvement, a decrease in medical complications related to drug
abuse, and overall improvement in quality of life.
Flynn (2011) reported that CBT (Butler, Chapman,
Forman, & Beck, 2006) has shown efficacy for reducing suicide and depression in many clients, issues that have been
cited for their comorbidity with SUDs. However, a major
criticism of CBT has been that a significant number of substance abusing clients have high rates of treatment recidivism.
According to Westra, Aviram, Connors, Kertes, and Ahmed
(2012), theoretical orientations that engaged CBT reported
high levels of client resistance. For instance, clients argued
with the therapist about completing assignments and were
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resistant toward recommendations, all leading to high rates of
recidivism. Further, the authors argued that outcomes suggested that high levels of client resistance correlated with
failure to complete treatment.
MI has been suggested as an augmentation to CBT to
address issues related to client resistance (Burke, 2011). MI
is a collaborative conversation, an approach that helps clients
with the primary purpose of strengthening a person’s motivation for change and, in particular, as Miller and Rollnick
(2013) put it, “. . .a person’s own motivation” (p. 12).
Techniques can include expressing empathy through reflective, high-quality listening, developing discrepancies between
client’s goals and their current behavior, rolling with a client’s
resistance rather than opposing it, using efficacious language,
among others. Depending on the needs of the client, each
technique can be utilized independently. For instance, clinicians might use the empathy technique to help clients feel less
judged and promote feelings of comfort that allows the client
to communicate openly with the professional (Iarussi, Tyler,
Littlebear, & Hinkle, 2013). Professionals use the discrepancy
technique to help clients explore the logic of behavior compared to a desired outcome. Rolling with resistance techniques
benefit both clients and professionals, and are a way to avoid
viewing resistance to change as a barrier, and rather allow
clients to rediscover discrepancies contributing to the resistance. Additionally, as clients begin to struggle with their
abilities to change behaviors, utilizing efficacious language
can help to support self-efficacy and optimism. Finally, utilizing reflective listening skills throughout the process is a technique that improves communication and reduces
misunderstanding between the client and clinician. The use
of MI techniques and skills helps to accomplish the overall
goal of expressing unconditional positive regard toward the
client and allows the professional to attend to cues not communicated (Westra et al., 2011).
There was an abundance of literature on the utilization of
CBT with the substance abusing population (Aviram &
Westra, 2011; Najavits & Hien, 2013; Windsor, Jemal, &
Alessi, 2015; Wolff, Frueh, Shi, & Schumann, 2012); however,
very few studies explored the benefits of utilizing MI as an
ongoing treatment to increase treatment completion rates.
The lack of research in this area presented a problem for
understanding influences that led to increasing clients’ treatment completion rates. A gap in the literature exists and there
has been a lack of research on the effectiveness of MI as an
ongoing adjunct treatment to CBT when treating individuals
with DD in intensive-outpatient (IOP) treatment. Closing the
gap provides advantages for assisting mental health practitioners in promoting completion rates for clients who are
engaged in CBT programming.
The current investigation
The purpose of this study was to investigate whether there
was a statistically significant difference in IOP completion
rates of DD clients who received an MI and CBT treatment
when compared to those receiving CBT alone. This study also
examined whether there was a significant difference in preand post-intervention behavioral self-efficacy to complete

treatment. A quantitative methodology was used in the current study, along with a quasi-experimental design to explore
whether clients’ IOP treatment completion rates statistically
significantly improved after receiving MI. The independent
variables in this study were MI and behavioral self-efficacy,
and the dependent variable was CBT completion rates. An
additional goal of conducting this study was to investigate
whether MI and CBT treatment statistically significantly
increased clients’ self-efficacy. The results of this study may
provide valuable directions for further exploring the use of MI
in conjunction with CBT as an evidence-based practice for
practitioners to utilize in the treatment of DD clients.

Method
Sampling procedures
The sample included observations from secondary data for
this study. The sample was chosen to represent three study
groups that are (1) a comparison group receiving CBT treatment alone; (2) a treatment group receiving MI and CBT
treatment; and (3) a treatment group receiving MI and CBT,
where self-efficacy was recorded pre- and post-MI. A random
generator table was used to randomly generate 280 cases from
a pool of available records (N = 5750). The researchers chose
the RAND function in Microsoft Excel 2010 in an effort to
reduce bias and provide representation of all levels of the
phenomenon (Chacón, Alvarado, & Santisteban, 2011).
According to a G*Power analysis, with a medium effect size,
an alpha level of .05, and a power level of .80, N = 280. The
current sample size (N = 307) more than satisfied the minimum sample size required for the study based upon the
G*Power analysis. Data collection occurred by randomly
choosing samples for analysis.
Participants
The population of individuals studied comprised DD clients
within the United States. According to SAMHSA (2014), the
DD population represents more than 40% of clients receiving
drug and alcohol treatment. The researchers intended to select
a sample for this study that would be representative of the
population of DD clients in the United States so that the
results of the current study could be helpful in understanding
the efficacy of MI as an intervention for increasing CBT
completion rates.
Participants included DD clients who received IOP treatment from a treatment center located in northeast Ohio.
Clients in the region were an appropriate representation of
people who suffer from mental health disorders and were
representative of the US mental health disorder population.
Results of at least two studies (Forand & DeRubeis, 2013;
Winstanley et al., 2012) indicated that studying a sample
from the northeast Ohio region was beneficial for understanding the effects of MI on completing CBT for DD clients in the
region.
The randomly selected sample included 210 males that
made up 68% of the sample and 97 females that made up
the rest of the sample. The ethnic makeup of the group was
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analyzed and it was found that African Americans (n = 152)
made up the largest proportion (49%) of the sample and
Whites (n = 140) made up the second largest proportion
(46%) of the group. People who identified as multi-racial
(n = 13) and Hispanics (n = 2) made up the rest of the sample.
Most participants had a high school diploma or equivalent
(n = 228) and made up 74% of the group. The second highest
proportion of the group were people with less than a high school
education (n = 51) who contributed to 17% of the sample. Clients
who either completed or attended college made up the rest of the
sample. The results indicated that approximately 1 in 10 people
who engaged in drug use had some college education or higher
and approximately 1 in 5 had less than a high school education.
Alcohol was the most popular drug of choice used among
clients (n = 155) and comprised 51% of the sample. The
results demonstrated that 5 in 10 people required treatment
for alcohol use. Marijuana was the next highest drug of choice
(n = 70) and is 23% of the sample, indicating that for clients
who use drugs, approximately one in four prefer to use
marijuana. The results showed that approximately 1 in 10
used crack/cocaine (n = 33) and the rate is similar to heroin/opioids/prescription category of drugs.

Results
A Chi-square analysis was conducted to determine if there
was a significant difference in rate of successful completion
based on receiving MI and CBT as compared to receiving

CBT alone. The test results were considered to be normally
distributed based on the sample size (N = 307). The statistical
assumptions did not indicate a statistical violation.
Those who completed CBT treatment and did not receive
MI comprised 26% of the overall treatment group, while
participants who completed CBT treatment and received MI
made up the remaining 74% of the group. Participants who
did not complete treatment (n = 61) were split into two
groups. Individuals who received MI and CBT (n = 31) comprised roughly 51% of all who did not complete treatment.
Figure 1 shows the frequencies for each group. The Chisquare results showed an association between receiving MI
and CBT as compared to receiving CBT alone χ2(1,
N = 307) = 11.85, p < .01, V = .20. The results demonstrated
a significant difference in the rate of successful completion of
treatment between all groups based on group and treatment
assignment.
The mean difference between pre-self-efficacy scores
(M = 7.68, SD = 2.55) and post-self-efficacy scores
(M = 9.06, SD = 1.29) was −1.38, indicating a 14% increase
in scores for participants receiving MI treatment. The median
score increased by .75 and the range decreased from 9 to 6
between the lowest and highest scores after MI treatment. The
results showed that participants with low self-efficacy scores
increased by 30% after receiving MI treatment.
Some clients started with a higher level of self-efficacy
(n = 26), but 61% of participants (n = 46) experienced a
positive change in self-efficacy. Some change was as little as

Figure 1. A pie chart showing the group frequency between participants completing treatment and the level of treatment provided.
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Table 1. Descriptive results of cross tabulation between treatment completed
treatment level.
Successful completion
CBT
MI and
alone
CBT
30
31
19
42.1
31.6% 14%

Completed CBT No observed count
Expected count
Percentage within successful
completion
Yes count
65
Expected count
76.1
Percentage within successful 68.4%
completion
Total
Count
95
Expected count
95.0
Percentage within successful 100.0%
completion

Total
61
61.0
19.9%

181
246
169.9
246.0
85.4% 80.1%
212
307
212.0
307.0
100.0% 100.0%

Table 2. A summary of paired samples t-test results.
Paired differences
Figure 2. A histogram showing the distribution of difference scores for pre and
post-self-efficacy scores.

95% CI of the
difference
M
SD SE Lower Upper
t
df p
Pair 1 self-efficacy pre-MI −1.38 2.04 .23 −1.85 −.92 −5.91 75 .001
– self-

less than 10%, while others experienced as much as an 80%
increase in self-efficacy to complete CBT when receiving MI.
Distributions of the difference scores are included in Figure 2.
The results of the paired samples t-test were significant t
(75) = −5.91, p < .001, ɳ2 = .32, suggesting that a significant
difference was found.

Discussion
Implications
Analyses of treatment completion rates suggested that the
expected completion rate for participants who received CBT
alone was n = 19; instead, this study found that n = 30 did not
complete treatment. These results indicate that more participants in the comparison group did not complete treatment
than had been expected. Similarly, fewer participants in this
condition (n = 65) completed treatment.
In comparison, those who received MI and CBT yielded
higher treatment completion rates (n = 181) than were expected
(n = 170) and also discontinued treatment (n = 31) at rates
lower than anticipated (n = 42). The critical Chi-square value
for rejecting the null hypothesis is χ2 = 3.84. Statistical analysis
produced a value (χ2 = 11.85) higher than the critical value,
indicating that the null hypothesis is rejected. The Cramer’s V
provided a small effect size (V = .20) between treatment completion and treatment level; the results were significant. A cross
tabulation of group results is in Table 1.
Analysis of self-efficacy suggests that there was a significant
difference in behavioral self-efficacy to complete treatment for
the experimental group after receiving MI in combination
with CBT treatment as compared to levels assessed before
receiving treatment. In addition, the 95% confidence interval
of −1.85 to −.92 indicated that since there is no zero value
within the interval, the populations mean difference is not
likely to be no difference, less than −1.85, or more than −.92,

supporting a rejection of the null hypothesis. A summary of
the results of this analysis can be found in Table 2.
In the early 1990s, Wierzbicki and Pekarik (1993) examined mean dropout rates in a meta-analysis of 125 studies.
Nearly half of individuals who presented for therapy dropped
out. In 2013, Brorson et al. found similar results. Although a
wide variety of treatment settings and diagnoses were
reviewed, including outpatient, inpatient, group, individual,
family, and couples therapy, the impact remains significant.
Economic, psychosocial, sociopolitical, and clinical factors are
linked to dropout. By identifying factors associated with dropout rates, conversely, self-efficacy to remain in treatment can
be salient to treatment success.
Counselors and psychotherapists, treatment centers, and
referral sources alike benefit from more efficacious treatment
options as well as better knowing levels of self-efficacy toward
treatment completion. Awareness of self-esteem and MI can
serve as a predictive factor in promoting outcome success.
Treatment planning can be challenging, particularly for individuals with addictive disorders co-occurring with mental
health issues, due to the complications of comorbidity, the
problem is exacerbated. As a result of the present study,
analysis of self-efficacy suggests that there was a significant
difference in behavioral self-efficacy that could lead to
increased therapy completion rates. By better preparing treatment in difficult populations of individuals who fall within
this category, options expand for counselors working in the
field.

Limitations
The sample size for participants in the self-efficacy group was
small (n = 81) and reduced the power level for the results,
possibly causing a Type I error, which is reporting a genuine
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effect in the study when there is not one. The overall sample
size was large enough for genuinely understanding the effects
of MI on completing CBT treatment, and the large sample
size provided high power level for rejecting the null hypothesis when false and avoiding a Type II error. Conducting the
study utilizing a quasi-experimental design contributed the
low representation in the self-efficacy group. A true experimental design study would allow for random selection prior
to starting the study and would mitigate for large enough
group sizes with attrition for each group in the study.

Directions for future research
The current study focused on DD clients with mental health
and SUDs, but future research could explore the treatment of
clients with triple diagnoses, that is, comorbid presentation of
SUDs, mental health disorders, and medical conditions.
Durvasula and Miller (2014) found that MI was effective for
treating triple diagnoses clients with CBT. Future research
could include studying the effectiveness of MI when treating
triple diagnoses clients with CBT including mental health
disorders, SUDs, and comorbidities such as diabetes and
hypertension. Studying clients with triple diagnoses including
medical conditions is valuable to the profession due to the
overwhelming number of clients who have a substance use
and mental health disorder that exacerbates the symptoms of
the medical conditions.
Self-efficacy theory was foundational in the study for
testing the effectiveness of MI with DD populations. MI
includes a self-efficacy component in the treatment; however, there are no known studies at this time on the effectiveness of planned behavior. According to Duncan, ForbesMcKay, and Henderson (2012), the theory of planned behavior is useful for predicting people’s intentions and actual
behavior. Duncan et al. (2012) stated when people intend to
meet certain goals, the likelihood of meeting those goals
increases due to planned behavior. The focus of future
studies can include utilizing the theory of planned behavior
as a pre-assessment to determine a client’s desire for making a change. Clients with a low level of desire for making
change are unlikely to complete CBT treatment and are
likely candidates for receiving MI intervention. Clients
with a high level of desire for making change are likely to
complete CBT treatment and may not require a full course
of MI intervention, if any at all (Duncan et al., 2012). An
additional recommendation includes treatment agencies
implementing an assessment or screening process that measures their clients’ self-efficacy levels prior to beginning
treatment. This vital information can assist treatment agencies with identifying clients’ beliefs about the change process and their ability to make the needed changes toward
treatment goals. In turn, this vital information will assist
clinicians with developing treatment plans that are individualized and geared toward the client’s needs. Finally, when
treatment agencies have the knowledge of the client’s selfefficacy levels, then implementation of MI with the stages of
change to motivate clients to increase their self-efficacy
levels can occur (Prochaska, Norcross, & DiClemente,
2013). The increase in self-efficacy levels would assist with

building a stronger therapeutic alliance and lead to higher
rates of treatment completion.

Conclusion
People with low levels of internal motivation often need a
cognitive boost to help complete treatment goals. There is a
significant association between receiving an MI intervention
and completing CBT treatment. MI is therefore a technique
that can be useful for building the internal motivation of
clients for completing goals such as CBT with the DD population. DD clients often experience treatment compliance issues
and are great candidates for receiving MI techniques.
Practitioners who utilize MI techniques at the beginning of
treatment can help motivate a client through increased selfefficacy and a propensity to remain in treatment. Clients are
more likely to complete CBT sessions when receiving motivation throughout the course of treatment. The results of the
current study suggest that clients who receive treatment that
incorporates MI techniques are more likely to complete
treatment.
Having a treatment tool that is effective for improving DD
clients’ motivation for completing treatment is useful for
practitioners. The results of the current study provided significant evidence to practitioners, researchers, and organizations on helping individuals with DD to complete CBT
treatment. Professionals working with the DD population
who received training to master the skills and abilities of MI
would be in a better position to serve that population by using
a tool that shown to be effective in its treatment.
Organizations that provide treatment to DD populations are
encouraged to promote the use of MI to help increase positive
treatment outcomes, such as preparing individuals who use
substances to return to society and live as productive citizens.
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